“…Orthogonal dCas9 (SpdCas9 and SadCas9) have been used for complex and inducible gene transcription control (Y. Gao et al, ) as well as for simultaneous imaging of multiple genomic loci (Chen et al, ). More recently, a trifunctional CRISPR system that combines 3 orthogonal Cas9 variants was developed for simultaneous gene activation (using LbdCas12a), repression (using SpdCas9) and deletion (using SaCas9) in the yeast Saccharomyces cerevisiae (Lian, HamediRad, Hu, & Zhao, ). However, to the best of our knowledge, no other studies have reported the use of multiple Cas9 orthologs for metabolic engineering of E. coli .…”